Speakers

Jane Davies is a Professor of Paediatric Respirology and Experimental Medicine at the National Heart and Lung Institute, Imperial College London, and an Honorary Consultant in Paediatric Respiratory Medicine at the Royal Brompton & Harefield NHS Foundation Trust, London. She is a physician–scientist specialising in rare diseases of childhood, particularly cystic fibrosis, where she leads an internationally recognised translational research programme focused on developing transformative therapies for people with cystic fibrosis.

Her work spans chronic lung infection in cystic fibrosis, lung infection and inflammation, lung physiology and imaging, and the design and delivery of clinical trials for new therapies, including CFTR modulators and gene therapy approaches. She has served as global and national lead investigator on dozens of phase I–IV clinical trials, including first-in-infant studies of small‑molecule CFTR modulators that contributed to the licensing of multiple disease‑modifying treatments.

Professor Davies directs or has directed key cystic fibrosis research infrastructures, including Strategic Research Centres on Pseudomonas aeruginosa infection, the Lung Clearance Index Core Facility for the European Cystic Fibrosis Society, and a major Cystic Fibrosis Trust/LifeArc Innovation Hub focused on polymicrobial infection and novel infection‑detection methods. Through these leadership roles, and as President of the European Cystic Fibrosis Society and a Fellow of the Academy of Medical Sciences, she helps shape national and international research strategy to accelerate improved outcomes and wellbeing for people living with cystic fibrosis.

In recognition of her contributions to cystic fibrosis research and care, she was elected a Fellow of the Academy of Medical Sciences in 2024 and appointed Officer of the Order of the British Empire (OBE) in the 2024 King’s Birthday Honours.

Dr Melissa Putman (MD, MMSc) is an adult and pediatric endocrinologist at Massachusetts General Hospital (MGH) in Boston, with subspecialty expertise in cystic fibrosis–related endocrine disease. She is internationally recognised for her work on cystic fibrosis–related diabetes (CFRD) and other endocrine complications of cystic fibrosis.

She cares for people with CF within the MGH Adult Cystic Fibrosis Program, where she serves as a cystic fibrosis endocrinologist. In addition, she is an Associate Professor of Medicine at Harvard Medical School and the Director of the MGH Diabetes Research Center, overseeing clinical research in diabetes, including technology‑focused interventions in high‑risk populations.

Her clinical interests encompass cystic fibrosis–related diabetes, cystic fibrosis‑related bone disease, and the use of diabetes technologies such as insulin pumps and continuous glucose monitoring in high‑risk and understudied groups. She founded and developed the CF Endocrine Program within the Massachusetts General Hospital and Boston Children’s Hospital cystic fibrosis centres, and she leads clinical research funded by the National Institutes of Health and the Cystic Fibrosis Foundation that has helped to define best practices for CFRD screening and management.

Dr Putman is recognised as an international leader in cystic fibrosis endocrinology and diabetes technology research and is frequently invited to lecture and educate on CFRD. She has received multiple mentoring and teaching honours, including the Endocrine Attending of the Year award at Boston Children’s Hospital and the J.F.P. Ullman Award for Exceptional Mentorship, and she remains actively engaged in mentoring junior faculty and fellows in endocrinology and cystic fibrosis research.